Project Grant HT9425261E264
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- Federal Grant Award Summary The University of Pittsburgh received a $1.144M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. This research initiative addresses overcoming immunotherapy resistance in acral melanoma, a critical oncology research priority within the DHA's comprehensive portfolio of biomedical research initiatives. The grant supports hypothesis-driven...
- Federal Project Grant Award Summary The University of Pittsburgh received a $1.18 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, through August 31, 2028. This award supports research focused on overcoming immunotherapy resistance in acral melanoma, a specialized oncology research initiative aligned with the Defense Health Agency's mission to advance biomedical solutions for Service...
- Federal Grant Award Summary The University of Pittsburgh received a $986,228 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025 through May 31, 2029. The award supports research to identify and characterize pathways of progression from acute pancreatitis to recurrent acute pancreatitis and chronic pancreatitis. This research is designed to generate scientific knowledge and insights that advance...
- Federal Grant Award Summary The University of Pittsburgh received a $1,008,763 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate profilin-1's (Pfn1) role in chromophobe renal cell carcinoma (ChRCC) mitochondria and tumorigenesis. The award, effective September 1, 2025, through August 31, 2029, supports hypothesis-driven biomedical research designed to advance innovative medical solutions for critical health...
- The University of Pittsburgh received a $726,989 Project Grant awarded September 15, 2025, by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct immunotherapeutic research targeting SLC39A9 in CDKN2A-low melanoma. The three-year award, with an ultimate completion date of September 14, 2028, supports research and development activities designed to advance innovative medical solutions for cancer treatment. The research will be conducted...
- Federal Grant Award Summary The University of Pittsburgh received a $300,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025, through September 30, 2027. The award supports research aimed at uncovering the nuclear antigens recognized by autoreactive T cells in systemic lupus erythematosus (SLE). This hypothesis-driven research initiative contributes to the DHA's broader mission of...
- Federal Grant Award Summary The University of Pittsburgh received a $2.67 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded August 15, 2025, with a completion date of August 14, 2029. The grant funds "A Collaborative Multiomic Approach to Pediatric Scleroderma (CMAPS) to Molecularly Characterize and Stratify Patients," a research initiative designed to advance the understanding and treatment of...
- This Project Grant award, worth $647,861.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The funding will support a 3-year research project evaluating the interplay between B-cells and T-cells within the tumor microenvironment of melanoma, and the impact on immune checkpoint blockade therapies. The University of Pittsburgh, a major recipient of federal biomedical research grants, will...
- Federal Project Grant Award Summary The University of Pittsburgh received a $1.8M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for research activities spanning May 1, 2026 through April 30, 2029. The grant supports investigative research into the mechanisms underlying ESR1-CCDC170 fusions in clinically aggressive, endocrine-resistant, and metastatic breast cancers, with the objective of identifying and developing...
- Federal Grant Award Summary The University of Pittsburgh received a $434,722 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with an ultimate completion date of August 14, 2029. The grant supports "A Collaborative Multiomic Approach to Pediatric Scleroderma" (CMAPS), a research initiative designed to molecularly characterize and stratify pediatric scleroderma patients. This four-year...